Keith W Marshall's Net Worth
$3.14 Million
Who is Keith W Marshall?
Keith W Marshall has an estimated net worth of $3.14 Million. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., and Conatus Pharmaceuticals Inc..
SEC CIK
Keith W Marshall's CIK is 0001714828
Past Insider Trading and Trends
2023 was Keith W Marshall's most active year for acquiring shares with 5 total transactions. Keith W Marshall's most active month to acquire stocks was the month of November. 2023 was Keith W Marshall's most active year for disposing of shares, totalling 17 transactions. Keith W Marshall's most active month to dispose stocks was the month of May. 2023 saw Keith W Marshall paying a total of $353,302.20 for 108,162 shares, this is the most they've acquired in one year. In 2023 Keith W Marshall cashed out on 743,668 shares for a total of $3,497,400.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Prometheus Biosciences, Inc. No price found
Chief Financial OfficerKeith W Marshall used to own units in Common Stock but no longer holds any shares there. From 2021 to 2023 Keith W Marshall acquired a total of 117,973 shares in Prometheus Biosciences, Inc. at a cost of $353,302.20, Keith also disposed a total of 117,973 shares of Prometheus Biosciences, Inc. equalling to $3,497,400.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -87.97K |
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +796.68% | 78.16K |
$3.10 | $242,302.20 | 87.97K |
Jun 2
| |||
Form 4
|
—
|
0
|
$56.06 | -$1,047,200.00 | 9.81K |
Apr 5
| |||
Form 4
|
—
|
0
|
$62.92 | -$1,184,300.00 | 9.81K |
Scheduled
|
Mar 6
| ||
Form 4
|
—
|
0
|
$61.54 | -$578,400.00 | 9.81K |
Scheduled
|
Feb 15
| ||
Form 4
|
—
|
0
|
$61.35 | -$576,500.00 | 9.81K |
Scheduled
|
Jan 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
∞
| 9.81K |
—
|
—
| 9.81K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Conatus Pharmaceuticals Inc. (HSTO) Snapshot price: $0.34
EVP, COO & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||